Discussion about recent FDA approval of Tibsovo with Dr. Amir Fathi, who is an associate professor of medicine at Harvard Medical School and the director of the leukemia program at Massachusetts General Hospital.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
